Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129753
Status:
WITHDRAWN
Last Update Posted:
2018-11-08
First Post:
2005-08-11
Brief Title:
Alemtuzumab Campath-1H Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkins Disease
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2006-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-11
First Submit QC Date:
August 11 2005
Study First Post Date:
2005-08-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-06
Last Update Post Date:
2018-11-08
Last Update Post Date Type:
ACTUAL